Determination of a Cut-off Point for Prostatic Specific Antigen to Avoid Unjustified Biopsy Among Asymptomatic Elderly Men (original) (raw)
The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: A validation study on a Turkish patient population in different age categories
Gorkem Mungan, Bülent Erol
The Kaohsiung Journal of Medical Sciences, 2014
View PDFchevron_right
The value of prostate specific antigen (PSA) density and free: total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation
Derek J Rosario
British journal of urology, 1998
View PDFchevron_right
Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population
Sibel Kiran
Clinical Chemical Laboratory Medicine, 2007
View PDFchevron_right
Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
Anil Mandhani
The Indian journal of medical research, 2014
View PDFchevron_right
Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
Dr. Shalini Agnihotri
Indian Journal of Urology, 2014
View PDFchevron_right
The predictive value of PSA in diagnosis of prostate cancer in non screened population
Snezana Cerovic
Acta chirurgica iugoslavica, 2005
View PDFchevron_right
Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
Ugur Yucetas
International braz j urol : official journal of the Brazilian Society of Urology
View PDFchevron_right
Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of age
levent verim
Asian Pacific journal of cancer prevention : APJCP, 2013
View PDFchevron_right
Predicting Prostate Biopsy Outcome by Findings at Digital Rectal Examination, Transrectal Ultrasonography, PSA, PSA Density and Free-To-Total PSA Ratio in a Population-Based Screening Setting
Alberino D'Agata
The International Journal of Biological Markers, 2001
View PDFchevron_right
Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate Cancer
Francisca Morales
Asian Pacific Journal of Cancer Prevention, 2015
View PDFchevron_right
Utility of Prostate Specific Antigen Density and Free to Total Prostate Specific Antigen Ratio for Detecting Prostate Cancer in Iranian Men: A Prospective Study of 187 Cases
Mohammad Reza Safarinejad
Current Urology, 2010
View PDFchevron_right
Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma
Niall Galloway
Urology, 1995
View PDFchevron_right
Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower—Correction
Howard Parnes
JAMA, 2006
View PDFchevron_right
Percentage of Free Prostate-specific Antigen: Implications in Modern Extended Scheme Prostate Biopsy
Khaled Fareed
Urology, 2011
View PDFchevron_right
Estimation of Prostate Cancer Risk on the Basis of Total and Free Prostate-Specific Antigen, Prostate Volume and Digital Rectal Examination
Ulf-Håkan Stenman
European Urology, 2002
View PDFchevron_right
The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number
Vidal Azancot, Dimitri Vordos
BJU International, 2010
View PDFchevron_right
Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics
Robert Veltri
Urology, 2001
View PDFchevron_right
Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
Valdemar Ortiz
International braz j urol, 2004
View PDFchevron_right
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL
Leonardo O Reis
BJU International, 2012
View PDFchevron_right
Is Prostate Biopsy Recommended In Men With a PSA Between 2,5 - 4 ng/mL?
hakan türk
Current Therapeutic Research, 2017
View PDFchevron_right
Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?
Dionysios Mitropoulos
Urology, 1996
View PDFchevron_right
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years
David Albala
BJUI, 2007
View PDFchevron_right
Prospective evaluation of prostate cancer detection by prostate-specific antigen-related parameters
Andrzej Borkowski
International Journal of Urology, 1999
View PDFchevron_right
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50�years
Cary N Robertson MD FACS, David Albala
BJU International, 2007
View PDFchevron_right
Free/total prostate-specific antigen ratio can prevent unnecessary prostate biopsies
Daniel Max Schmid
Urology, 1998
View PDFchevron_right
The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL
Orcun Celik
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2018
View PDFchevron_right
Utility of Volume Adjusted Prostate Specific Antigen Density in the Diagnosis of Prostate Cancer in Arab Men
Elijah Kehinde, Tariq Sinan
International Urology and Nephrology, 2005
View PDFchevron_right
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer
Robert Veltri
Urology, 2002
View PDFchevron_right
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran
Mohammad Reza Safarinejad
Annals of Oncology, 2006
View PDFchevron_right
Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities
Yannis V Simos
2019
View PDFchevron_right